The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
